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Abstract
Background: Susceptibility to atopy originates from effects of the environment on genes. Birth order has been
identified as a risk factor for atopy and evidence for some candidate genes has been accumulated; however no
study has yet assessed a birth order-gene interaction.
Objective: To investigate the interaction of IL13 polymorphisms with birth order on allergic sensitization at ages 4,
10 and 18 years.
Methods: Mother-infant dyads were recruited antenatally and followed prospectively to age 18 years.
Questionnaire data (at birth, age 4, 10, 18); skin prick test (SPT) at ages 4, 10, 18; total serum IgE and specific
inhalant screen at age 10; and genotyping for IL13 were collected. Three SNPs were selected from IL13: rs20541
(exon 4, nonsynonymous SNP), rs1800925 (promoter region) and rs2066960 (intron 1). Analysis included
multivariable log-linear regression analyses using repeated measurements to estimate prevalence ratios (PRs).
Results: Of the 1456 participants, birth order information was available for 83.2% (1212/1456); SPT was performed
on 67.4% at age 4, 71.2% at age 10 and 58.0% at age 18. The prevalence of atopy (sensitization to one or more
food or aeroallergens) increased from 19.7% at age 4, to 26.7% at 10 and 41.1% at age 18. Repeated measurement
analysis indicated interaction between rs20541 and birth order on SPT. The stratified analyses demonstrated that
the effect of IL13 on SPT was restricted only to first-born children (p = 0.007; adjusted PR = 1.35; 95%CI = 1.09,
1.69). Similar findings were noted for firstborns regarding elevated total serum IgE at age 10 (p = 0.007; PR = 1.73;
1.16, 2.57) and specific inhalant screen (p = 0.034; PR = 1.48; 1.03, 2.13).
Conclusions: This is the first study to show an interaction between birth order and IL13 polymorphisms on allergic
sensitization. Future functional genetic research need to determine whether or not birth order is related to altered
expression and methylation of the IL13 gene.
Introduction
Atopy has been defined as the propensity of an indivi-
dual to produce IgE in response to allergen and a pre-
disposition to the development of allergic diseases, such
as asthma, atopic dermatitis, food allergy or hay fever. It
is defined operationally by elevations in serum levels of
immunoglobulin E (IgE) reactive with allergens or skin
test reactivity to allergens [1]. Thus atopy is strictly
linked to IgE production and describes the personal or
familial propensity to become sensitized and produce
IgE antibodies in response to environmental triggers [2].
The documented increase in childhood asthma and
other atopic disorders over the past three decades has
necessitated a search for possible underlying mechan-
isms and mediators [3,4]. Genetic variation has been
documented to play a role; however, when found, gene
effects for allergic diseases are typically small and not
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t h a tac h a n g ei nt h eg e n e t i cp o o li si n s u f f i c i e n tt o
account for the temporal and spatial correlates of this
increase in prevalence, and suggest that modifications of
gene expression and function may be more important
[5,6]. Such modifications of gene expression are thought
to result from gene-environment interactions occurring
before and after birth. Indeed, previous evidence sug-
gests that developmental processes may modify the
impact of genetics on atopy development later in life
[7,8]. Thus, current etiological research is focusing on
modifiers of gene effects as possible precipitating factors
for the increasing prevalence of atopy in childhood.
Previous studies have assessed two related ideas - the
hygiene hypothesis and the birth order effect [9]. The
hygiene hypothesis suggests that exposure to infections
after birth (due to transmission from older siblings or
other children), may influence the development of the
immune system along a non-allergic (T helper 1; Th1)
pathway, leading to a reduced risk of asthma and other
allergic diseases. Although still under investigation, the
hygiene hypothesis may explain observed associations
between family size, birth order, day-care attendance,
and the risk of asthma and allergy. According to the
hygiene concept, the effect of birth order is through sib-
ling hierarchy, where the younger child is prone to
infection from the older sibling and hence is at lower
risk of atopy.
Other studies suggest that birth order may act
through a different mechanism [9]. In utero sensitization
as a possible mechanism of modification of gene effects
has been proposed, where birth order, as an indicator of
variations in prenatal exposure, acts independent of the
number of siblings [10,11]. A previous report by our
group [12] suggested that the birth order effect may
result from in utero exposure as indicated by changes in
maternal IgE [12]. If a protective effect of birth order is
a l r e a d yp r e s e n ta tt h et i m eo fb i r t ho ft h ec h i l d ,t h e n
the effect of hygiene later in childhood may not be as
relevant as is currently thought. In support of this expla-
nation, other non-allergic diseases such as preeclampsia
a r em o r ec o m m o ni nf i r s tb o r nc h i l d r e no rf i r s tp r e g -
nancies, when compared to subsequent births or preg-
nancies, [13] suggesting altered intra uterine immune
adaptation as a possible underlying mechanism.
In a recent review, Vercelli [1] suggested that one of
the major challenges facing geneticists is to understand
how environmental and developmental factors interact
with genetic determinants to increase disease suscept-
ibility. Previous studies have assessed the individual
effects of birth order [10,14,15] and IL13 polymorphisms
[16-21] on allergic phenotypes. It is noteworthy that
none of these reports examined the possible interaction
between birth order and IL13 polymorphisms on child-
hood atopy.
In previous reports by our group and other research-
ers, birth order has been repeatedly found to be asso-
ciated with atopic markers. For instance, we found that
cord serum IgE was reduced in offspring with higher
order, indicating that the sibling effect may have its ori-
gin in utero [12], before any hygiene effect in early
childhood could affect the offspring. In addition, we
found that the number of live offspring significantly
reduces maternal IgE [22], which supports the idea that
maternal immune tolerance against allergens may
increase with increasing order of live offspring; this may
transmit a lower risk of developing atopy to children of
a higher birth order.
Our a priori hypothesis was that the birth order effect
may interact with the genetic predisposition of the off-
spring in influencing future atopic manifestations. In
order to test this hypothesis, we chose one of the most-
studied “atopy genes,” IL13. This choice seems appropri-
ate because, if a gene-by-birth order interaction exists, it
would be best demonstrated with a known gene. Finding
such an interaction with a novel gene that does not have
the kind of consistent replication so far demonstrated
for IL13 may not be as scientifically robust.
This report will be the first study to investigate the
interaction between these important risk factors during
early childhood, as well as sustained effects in adoles-
cence, testing both the main effects and the interaction
effects of the IL13 gene with prenatal factors.
Materials and methods
Study population
The study participants were mother-infant pairs enrolled
in the 1989 Isle of Wight birth cohort study. This study
represents an unselected whole population birth cohort
based on the Isle of Wight, U.K. The Isle of Wight is an
island (13 × 23 miles) just off the South Coast of
England with a resident population of 130,000. The
population is stable to the extent that the majority of
participants in the cohort has not moved away and was
thus available for follow up. This makes the island
particularly attractive for long-term prospective epide-
miological studies.
Between January 1989 and February 1990, children
born on the Isle of Wight, U.K. were recruited to parti-
cipate in a longitudinal study (n = 1,456). The local
Research Ethics Committee approved the study and
informed written parental consent was obtained for all
the participants at recruitment and subsequently at each
follow up. This whole-population birth cohort was lar-
gely Caucasian (99%) and was living in a semi-rural,
non-farming environment with no heavy industry.
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detail elsewhere [23,24]. Briefly, pregnant women were
recruited prenatally and data from birth records and
extensive questionnaires were collected, including infor-
mation on family history of asthma and allergy, as well
as maternal smoking habits. At ages 1, 2, 4, 10 and 18
years, the original questionnaire-based information was
updated, a study investigator performed physical exami-
nations on the children, and symptoms of asthma and
allergic diseases were recorded. Skin prick tests (SPT) to
common food and aero-allergens were administered at
the 4, 10 and 18 year follow-up visits [25], and at age
10, anti-coagulated blood samples were collected and
stored frozen for subsequent DNA analysis. Also at age
1 0 ,t o t a ls e r u mI g Ea n di n h a l a n tI g Es c r e e nw e r ep e r -
formed in the blood samples of the children. Further
information was collected at the 10 and 18 year visits
using standardized International Study of Asthma and
Allergy in Childhood (ISAAC) questionnaires.
Study variables
This is a population-based association study that tests
the interaction effects between IL13 SNPs and birth
order on atopic outcomes. Thus, the main exposure
variables involved in the interaction terms were IL13
polymorphisms and birth order. Outcome variables
include skin prick tests at ages 4, 10, and 18, total IgE
at birth (cord serum) and at age 10, and inhalant IgE
screen at age 10. The potential confounders we adjusted
for were gender, environmental tobacco smoke expo-
sure, family SES cluster, and gestational age. Gender
was classified into male and female while gestational age
was assessed in weeks. Other variables are described in
greater detail below.
IL13 genotyping
Genomic DNA was isolated from blood samples using
QIAamp DNA Blood Kits (Qiagen, Valencia, CA) or the
ABI PRISM™ 6100 Nucleic Acid PrepStation (Applied
Biosystems, Foster City, CA). Polymorphisms in the
IL13 gene were examined using the SNPper and Applied
Biosystems databases. Genotyping was conducted by
fluorogenic 5’ nuclease chemistry PCR using Assays on
Demand kits cycled on a 7900HT Sequence Detection
System (Applied Biosystems, Foster City, CA), or biotin-
streptavidin-based pyrosequencing performed on PSQ-
96 instrumentation (Biotage AB, Uppsala, Sweden).
IL13 is a small gene (2.9 kb) characterized by exten-
sive linkage disequilibrium, thus genotyping a few poly-
morphisms provided adequate assessment of genetic
associations. Five IL13 SNPs were genotyped (Table 1):
rs1800925 at the promoter region, rs2066960 at intron 1
and rs1295686 at intron 3 positions, rs20541 at the cod-
ing exon 4 position ([G] Arg to [A] Gln at amino acid
position 144) and rs1295685 at the 3’ UTR/exon 4 posi-
tion of the gene. Each of these SNPs had a minor allele
frequency ≥ 19%.
Using the Haploview program [26], three of the five
single nucleotide polymorphisms (SNPs) of the interleu-
kin 13 gene were in a linkage disequilibrium (LD) block.
SNP selection was carried out using the tag-SNP
approach. Since rs1295686, rs20541 and rs1295685 were
in the same LD block (Figure 1 in [27]), we selected
rs20541 for further analysis. In addition to being the
non-synonymous SNP among these three, it is also the
IL13 SNP that has been most studied [17,21,28-31].
Birth order
Birth order was obtained from the questionnaire data
collected at birth. We defined three groups for this ana-
lysis: “first”, “second”, and “third and higher” order birth
positions. Birth order equals the number of older sib-
lings plus one [12].
Skin Prick Testing (SPT)
Skin prick testing to 14 common food and aero-aller-
gens was performed at 4 (n = 981), 10 (n = 1036) and
18 years (n = 845) using a standard battery of food and
aeroallergens (ALK, Horsholm, Denmark), which have
Table 1 Genotype proportions for IL13 single nucleotide
polymorphisms (SNPs)
SNPs Position (bp) Location Genotype Frequency (%)
rs1800925 132,020,708 Promoter CC 577 (63.6)
(-1112C/T) CT 295 (32.5)
TT 35 (3.9)
Total 907 (100.0)
rs2066960 132,022,334 Intron 1 CC 729 (81.5)
AC 157 (17.6)
AA 8 (0.9)
Total 894 (100.0)
rs1295686 132,023,742 Intron 3 CC 483 (64.6)
CT 240 (32.1)
TT 25 (3.3)
Total 748 (100.0)
rs20541 132,023,863 Exon 4 GG 583 (64.4)
(R130Q) GA 291 (32.1)
AA 32 (3.5)
Total 906 (100.0)
rs1295685 132,024,344 Exon 4 GG 584 (64.5)
GA 280 (30.9)
AA 41 (4.5)
Total 905 (100.0)
Ogbuanu et al. Allergy, Asthma & Clinical Immunology 2010, 6:6
http://www.aacijournal.com/content/6/1/6
Page 3 of 13been previously described [32]. After 15 minutes, a
mean wheal diameter ("sum of longest diameter and dia-
meter diagonal to it” d i v i d e db y2 )o fa tl e a s t3m m
greater than the negative control was considered evi-
dence of sensitization. Sensitization to at least one food
or aeroallergen was recorded as a positive reaction to
SPT.
Serum Total IgE Determination
Total IgE was measured in samples of cord serum (n =
1340) and serum collected at age 10 (n = 923). Total
IgE in cord serum was measured using Pharmacia IgE
EIA® (Pharmacia Diagnostics AB, Uppsala, Sweden) [33],
which is designed to measure IgE between 0.2 to 50 kU/
L on 0.1 ml of serum or plasma [34,35]. Maternal IgE
and IgE at age 10 were determined using PRIST® (Phar-
macia Diagnostics AB, Uppsala, Sweden) designed
to measure IgE between 2.0 to 1000 kU/L. For our
analysis, maternal IgE was dichotomized into < 100 and
≥ 100 kU/L.
Maternal Atopic Status
Using information from questionnaires on maternal ato-
pic history (Yes vs. No; n = 1213) and data from the mea-
sured maternal IgE level at birth (n = 1037), we created a
composite variable with four levels: “definite” maternal
atopic status (elevated IgE, positive history of atopy, n =
163); “latent” (elevated IgE, negative history, n = 201);
“probable” (normal IgE, positive history, n = 121); and
“none” (normal IgE, negative history, n = 552).
Serum Specific Inhalant IgE Screening
The inhalant screen was a non-quantitative test for spe-
cific allergens. The test was positive if it detected anti-
bodies against one or more of the following allergens;
house dust mite (D. pteronyssinus and D. farinae), cat
dander, dog dander, horse dander, timothy grass, clados-
porium, silver birch, olive, mugwort and nettle. Blood
samples were allowed to stand and coagulate in Gel and
Clot Activator tubes (Vacutainer Systems, Europe) for at
least 10 minutes. They were then centrifuged at 3000
revolutions per minute for a further 15 minutes. Serum
was then stored at minus 40°C until analysis for serum
IgE. Results were recorded as either positive or negative
to inhalant IgE screen. Individuals were classified as
positive if they had IgE to one or more of the above
tested aero-allergens.
Family Social Status Cluster
“Family social status cluster” is a composite variable that
accounts for “socio-economic status” broadly defined
[36]. The Isle of Wight population has been character-
ized as semi-rural, with most families (63%) residing in
“owner-occupied” homes that have been owned by their
families for decades. In order to correctly classify “social
status,” we chose to cluster family social status using the
following three variables: a) the British socioeconomic
classes (1 - 6) derived from parental occupation
reported at birth; b) the number of children in the
index child’s bedroom (collected at age 4); and c) family
income at age 10. This composite variable captures the
family social class across the entire study period and has
been described in more detail elsewhere [36].
Environmental Tobacco Smoke Exposure
Information on tobacco smoking by mothers (during
pregnancy and later), by fathers or any other individual
inside the home was recorded at recruitment and
updated at each follow-up. Exposures to environmental
tobacco smoke (ETS) in the household and maternal
smoking during pregnancy were combined and classified
into three groups. When mothers did not smoke during
pregnancy and there was no exposure to household ETS
in children up to the age of 10 years, children were cate-
gorized as “ETS-0”. When mothers did not smoke dur-
ing pregnancy but household members smoked within
t h eh o m ea ts o m ep o i n tu pt ot h ec h i l d ’sa g eo f1 0
years, the exposure status was categorized as “ETS-1”.
When mothers smoked during pregnancy and the chil-
dren were also exposed to household ETS at some point
up to the age of 10 years, the exposure was categorized
as “ETS-2”. None of the children had mothers who
smoked during pregnancy with no exposure to house-
hold tobacco smoke after birth [28].
Data analysis and statistics
Serum total IgE at age 10 (dichotomized into ≤ 200 kU/
L and >200 kU/L) and inhalant IgE at age 10 (dichoto-
mized into positive or negative) were analyzed as binary
outcomes. Because SPT was measured at ages 4, 10 and
18 years, the three measurements for each individual
child were correlated over time. To account for these
correlations, we estimated the effect of birth order, IL13
polymorphisms, and their interaction on SPT, using
generalized estimating equations (GEE). In addition,
since SPTs are prevalent outcomes, we did not estimate
odds ratios but prevalence ratios (PROC GENMOD
with the REPEATED statement and LOG link function
in SAS). The association of birth order with IgE and the
inhalant screen measured at age 10 was also determined
using prevalence ratios (PRs).
In order to exclude the possible confounding effect of
correlated variables, multivariable regression was used to
explore the predictive effect of each variable, adjusting
for all potential confounders. Assessment of interaction
was carried out using backward elimination from the
full model (which contained three birth order by IL13
SNP interaction terms). The significance level for the
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interaction on a multiplicative scale (log-linear models),
and results were presented by stratification when the
“birth order by gene” effect was significant. Stratification
assesses interaction between IL13 and birth order on an
additive scale, meaning that the combined effect is more
than the sum of the single effects, whereas multiplicative
interaction implies that the combined effect is more
than the product of the individual effects.
Following the pattern of previous publications
[27,37,38], we estimated the effect of IL13 polymor-
phisms using the dominant model, i.e. the heterozygous
genotype was combined with the homozygous minor
allele genotype in one category, while the homozygous
common allele served as the referent group. This classi-
fication was also necessary because relatively few indivi-
duals were homozygous for the risk/minor allele, as has
been reported and proposed in previous reports of the
IL13 gene [38].
Results
Participant demographic characteristics
Of the available 1536 children born during the recruit-
ing period, 94.8% (1456/1536) consented to participate
in this study. Birth order information was available for
83.2% (1212/1456) of the original birth cohort; skin
prick test was performed on 67.4% (981/1456) of the
original cohort at age 4, 71.2% (1036/1456) at age 10
and 58.0% (845/1456) at age 18 years. Of all the children
w h ow e r es k i n - p r i c kt e s t e d ,t h ep r e v a l e n c eo fa t o p y
(positive reaction to one or more allergens) was 19.7%,
26.7% and 41.1% at ages 4, 10 and 18 years respectively.
Serum total IgE measurements at age 10 were avail-
able for 65.5% (953/1456) of the original cohort. Com-
parison of the demographic data between children with
and without IgE measurements at age 10 revealed no
evidence of selection bias in the major variables used for
this analysis; however, children with no IgE measure-
ments had greater environmental tobacco smoke expo-
s u r ea n dw e r em o r el i k e l yt oc o m ef r o mt h el o wf a m i l y
social status cluster (Table 2).
Association of birth order and IL13 polymorphisms with
total serum IgE and inhalant IgE screen at age 10, and
with skin prick test positivity at ages 4, 10 and 18 years
Univariable analysis
Univariable analysis showed no significant association
between birth order and IgE (serum total IgE and serum
specific inhalant IgE screen positivity) at age 10 years
(Table 3). Unadjusted bivariable analysis also showed no
evidence of an association between birth order and SPT
at ages 4, 10 and 18 years (Table 4). In addition, IL13
polymorphisms were not significantly correlated with
atopic markers at ages 4, 10 and 18 years, except for
rs2066960, which was a significant predictor of elevated
serum IgE (>200 kU/L) at age 10 years (p = 0.011)
(Table 3).
Other significant predictors of elevated serum IgE at
age 10 years in the univariable analysis included mater-
nal IgE (p = 0.009), maternal atopic status (p = 0.006),
elevated cord serum IgE (p = 0.004) and prematurity (p
= 0.008) (Table 3). Similarly, maternal history of atopy,
maternal IgE, maternal atopic status and gender were
significantly associated with SPT at ages 10 and 18, but
not at age 4 years (Table 4). Only elevated cord serum
IgE was significantly associated with skin test positivity
at 4 years.
Multivariable analysis
Elevated serum IgE at age 10 years Using multivariable
log-linear regression analysis and after mutually adjusting
for potential confounders, there was a significant interac-
tion between rs1800925 and birth order on elevated serum
total IgE at age 10 years (p = 0.023). To unfold this inter-
action, we stratified the analysis by birth order (Table 5).
After stratification, the explanatory model showed the
effect of rs1800925 on elevated serum total IgE at age 10
to be restricted only to first-born children (p = 0.007;
adjusted Prevalence Ratio (PR) = 1.73; 95% CI = 1.16,
2.57). No other significant associations were found in this
model (Table 5).
Serum specific inhalant IgE screen positivity at age
10 years In the multivariable log-linear regression analy-
sis and after mutually adjusting for potential confound-
ing variables, we identified a statistically significant
interaction between rs20541 and birth order on serum
specific inhalant IgE positivity at age 10 (p = 0.029). To
demonstrate this interaction, we stratified the analysis
by birth order (Table 6). The stratified analysis showed
the effect of IL13 on positive inhalant IgE screen at age
10 to be restricted only to first-born children (p = 0.034;
adjusted PR = 1.48; 95% CI = 1.03, 2.13). No other sig-
nificant associations were found.
Skin prick tests at 4, 10 and 18 years: Cross-sectional
analyses We assessed the interaction of IL13 poly-
morphisms with SPT at the different time-points. Multi-
variable analysis showed significant interaction on a
multiplicative scale between IL13 and birth order on
SPT positivity at age 10 (rs20541, p = 0.07) and age 18
(rs20541, p = 0.030 and rs2066960, p = 0.027) but not
at age 4. To further demonstrate and compare these
effects on an additive scale, we stratified by birth order
at each time-point. Among first-born children, minor
allele carrier-ship of rs20541 showed a trend towards a
higher risk of skin sensitization at age 4 (PR = 1.59; 95%
CI = 1.01, 2.50), age 10 (PR = 1.48; 95% CI = 0.99, 2.20)
and 18 years (PR = 1.21; 95% CI = 0.86, 1.69). On the
other hand, there was no such increased risk of atopy
among second-born children at age 4 (PR = 0.81; 95%
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and 18 years (PR = 0.76; 95% CI = 0.51, 1.14). Com-
pared to the referent group, in children with a birth
order of 3 or greater, there was also a higher but non-
significant prevalence ratio of SPT in children with
minor allele carriership of rs20541.
Skin prick tests at 4, 10 and 18 years: Repeatedmea-
surement analysis After confounder adjustment, the
multivariable repeated measurement regression analysis
showed a significant interaction between rs20541 and
birth order on SPT at ages 4, 10 and 18 years at an
alpha level of 0.1 (p = 0.076). To further describe this
interaction, we stratified the statistical model by birth
order (Table 7). Table 7 focuses on the effect of IL13
polymorphism on SPT within each birth order category.
The stratified analysis showed that the effect of IL13 on
S P Ta ta g e s4 ,1 0a n d1 8w a se v i d e n to n l ya m o n gf i r s t -
born children (p = 0.007; adjusted PR = 1.35; 95% CI =
1.09, 1.69), with borderline significance for second-born
children. Children with a birth order of 3 and higher
showed an increased but non-significant prevalence
ratio of SPT positivity.
Comparing children from low socio-economic
backgrounds with those from the high end of the
social status scale, it is also evident from Tables 5 to
7 that there is a decreasing (though not statistically
significant) trend of risk for atopy as birth order
increases from one to three and above. First born
children from low social status backgrounds had
increased risk of atopy (PR = 1.51; 95% CI = 0.93,
2.45, not significant; Table 7), while third and higher
order birth children were protected from the risk of
atopy (PR = 0.34; 95% CI = 0.16, 0.73, p = 0.006;
Table 7). In addition, gestational age was a signifi-
cant predictor of skin test sensitivity for second and
higher order birth children (p = 0.03 and 0.01
respectively; Table 7).
Discussion
Our analyses showed a statistically significant interaction
between IL13 polymorphisms and birth order for ele-
vated serum IgE at age 10, serum inhalant specific IgE
positivity at age 10, and for SPT at ages 4, 10 and
18 years. An interaction on an additive scale was found
both in the cross-sectional analysis and in the repeated
measurement analysis. The predictive value of IL13 gen-
otypes on the atopic markers was restricted only to first
born children.
Table 2 Comparison between children with and without total serum IgE measurements at age 10
IgE at age 10 (n (%)) No IgE at age 10 (n (%)) Exact
Study Variables N = 953 N = 583 p-values
Birth order
- First 354 (41.0) 156 (44.7) 0.50
- Second 303 (35.1) 116 (33.2)
- Third or higher 206 (23.9) 77 (22.1)
Family Social Status Cluster*
- High 80 (8.5) 31 (7.5) 0.02
- Middle 737 (78.0) 300 (72.8)
- Low 128 (13.5) 81 (19.7)
Environmental Tobacco Exposure**
- ETS-0 451 (47.5) 196 (36.0) <0.0001
- ETS-1 300 (31.6) 164 (30.1)
- ETS-2 199 (21.0) 185 (33.9)
Gender
- Male 479 (50.3) 306 (52.7) 0.37
- Female 474 (49.7) 275 (47.3)
Prematurity (weeks)
- < 37 26 (2.8) 23 (4.1) 0.23
- ≥ 37 904 (97.2) 544 (95.9)
Low Birth Weight (g)
- < 2500 33 (3.6) 28 (4.9) 0.23
- ≥ 2500 894 (96.4) 539 (95.1)
*"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
** ETS-0: mother did not smoke during pregnancy and children not exposed to household environmental tobacco smoke (ETS);
ETS-1: mother did not smoke during pregnancy, but children were exposed to household ETS;
ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
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factors
Elevated serum IgE (age 10) Inhalant IgE +ve (age 10)
n (%) Exact n (%) Exact
Study Variables N = 953 p-values N = 952 p-values
rs1800925:
- TT/CT 108 (33.0) 0.086 117 (35.9) 0.191
- CC 173 (27.6) 197 (31.5)
rs2066960:
- AA/AC 62 (38.0) 0.011 58 (35.8) 0.410
- CC 219 (27.7) 256 (32.4)
rs20541:
- AA/GA 104 (32.6) 0.153 114 (35.9) 0.189
- GG 177 (27.9) 200 (31.6)
Birth order
- First 98 (27.7) 0.659 116 (32.8) 0.683
- Second 91 (30.0) 105 (34.8)
- Third or higher 64 (31.1) 64 (31.1)
- Latent 33 (47.8) 31 (44.9)
Family Social Status Cluster*
- High 22 (27.5) 0.328 22 (27.5) 0.363
- Middle 213 (28.9) 251 (34.1)
- Low 45 (35.2) 38 (29.7)
Environmental Tobacco Exposure**
- ETS-0 142 (31.5) 0.463 160 (35.6) 0.237
- ETS-1 85 (28.3) 89 (29.7)
- ETS-2 54 (27.1) 64 (32.2)
Gender
- Male 146 (30.5) 0.523 178 (37.2) 0.006
- Female 135 (28.5) 136 (28.7)
Prematurity (weeks)
- < 37 14 (53.9) 0.008 14 (53.9) 0.032
- ≥ 37 257 (28.4) 290 (32.1)
Low Birth Weight (g)
- < 2500 8 (24.2) 0.566 11 (33.3) 1.000
- ≥ 2500 265 (29.6) 291 (32.6)
Maternal History of Atopy
- Yes 100 (30.7) 0.600 125 (38.3) 0.013
- No 181 (28.9) 189 (30.2)
Maternal IgE
- > 100 65 (37.4) 0.009 73 (42.0) 0.002
- ≤ 100 130 (26.7) 140 (28.8)
Maternal Atopic Status***
- Definite 32 (30.5) 0.006 42 (40.0) 0.014
- Latent 33 (47.8) 31 (45.0)
- Probable 31 (26.3) 35 (30.0)
- None 99 (26.8) 105 (28.5)
Cord Serum IgE
- ≥ 0.5 34 (43.6) 0.004 37 (47.4) 0.005
- < 0.5 202 (27.4) 229 (31.0)
*"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
** ETS-0: mother did not smoke during pregnancy and children not exposed to household ETS; ETS-1: mother did not smoke during pregnancy, but children
were exposed to household ETS; ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
***Maternal atopic status was classified into Definite (elevated IgE, positive history); Latent (elevated IgE, negative history); Probable (normal IgE, positive history);
and None (normal IgE, negative history).
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Page 7 of 13Table 4 Univariate analysis of the association of positive skin prick test (SPT) with IL13 and prenatal factors
Positive SPT (age 4) Positive SPT (age 10) Positive SPT (age 18)
n (%) Exact n (%) Exact n (%) Exact
Study Variables N = 981 p-values N = 1,036 p-values N = 845 p-values
rs1800925:
- TT/CT 56 (21.8) 0.317 94 (28.7) 0.365 105 (43.6) 0.354
- CC 137 (18.9) 183 (25.9) 242 (40.1)
rs2066960:
- AA/AC 31 (23.9) 0.195 50 (30.7) 0.247 47 (39.8) 0.840
- CC 162 (19.0) 227 (26.0) 300 (41.3)
rs20541:
- AA/GA 54 (20.9) 0.584 89 (27.6) 0.705 98 (42.1) 0.754
- GG 139 (19.2) 188 (26.3) 249 (40.7)
Birth order
- First 84 (21.1) 0.549 107 (27.2) 0.950 130 (39.5) 0.121
- Second 67 (19.6) 89 (27.6) 116 (47.4)
- Third or higher 42 (17.5) 57 (26.4) 73 (39.3)
Family Social Status Cluster*
- High 20 (23.8) 0.492 19 (22.9) 0.516 25 (36.8) 0.023
- Middle 150 (19.7) 221 (27.7) 276 (43.1)
- Low 23 (17.2) 35 (24.3) 33 (29.7)
Environmental Tobacco Exposure**
- ETS-0 100 (21.9) 0.145 141 (28.9) 0.213 183 (43.8) 0.245
- ETS-1 63 (19.4) 86 (26.2) 97 (38.5)
- ETS-2 30 (15.2) 49 (22.6) 63 (37.5)
Gender
- Male 109 (22.1) 0.055 158 (30.6) 0.005 188 (46.2) 0.002
- Female 84 (17.2) 119 (22.9) 156 (35.7)
Prematurity (weeks)
- < 37 5 (17.2) 1.000 12 (41.4) 0.086 9 (39.1) 1.000
- ≥ 37 183 (19.7) 257 (26.2) 321 (40.4)
Low Birth Weight (g)
- < 2500 4 (11.1) 0.283 11 (31.4) 0.559 9 (34.6) 0.685
- ≥ 2500 184 (20.0) 256 (26.3) 321 (40.7)
Maternal History of Atopy
- Yes 75 (22.1) 0.178 117 (32.7) 0.002 137 (47.6) 0.005
- No 118 (18.4) 160 (23.6) 207 (37.4)
Maternal IgE
- > 100 40 (22.4) 0.223 68 (34.3) 0.002 78 (48.8) 0.002
- ≤ 100 90 (18.0) 116 (22.4) 146 (34.5)
Maternal Atopic Status***
- Definite 20 (19.2) 0.355 40 (33.9) 0.010 48 (49.5) 0.008
- Latent 20 (26.7) 28 (35.0) 30 (47.6)
- Probable 24 (18.8) 32 (25.0) 42 (40.0)
- None 66 (17.7) 84 (21.5) 104 (32.7)
Cord Serum IgE
- ≥ 0.5 29 (32.2) 0.002 32 (35.6) 0.042 37 (50.0) 0.060
- < 0.5 134 (17.8) 201 (25.2) 253 (38.4)
*"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
** ETS-0: mother did not smoke during pregnancy and children not exposed to household ETS; ETS-1: mother did not smoke during pregnancy, but children
were exposed to household ETS; ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
***Maternal atopic status was classified into Definite (elevated IgE, positive history); Latent (elevated IgE, negative history); Probable (normal IgE, positive history);
and None (normal IgE, negative history).
Ogbuanu et al. Allergy, Asthma & Clinical Immunology 2010, 6:6
http://www.aacijournal.com/content/6/1/6
Page 8 of 13Table 5 Multivariate analysis of the association of elevated total serum IgE at age 10 (>200 kU/L) with IL13
polymorphisms and prenatal factors, stratified by birth order (n = 588) (PR = Prevalence Ratio)
1
st Born 2
nd Born 3
rd and Higher
Study Variables p PR (95% CI) p PR (95% CI) p PR (95% CI)
n = 246 n = 212 n = 130
rs1800925:
-TT/CT vs. CC 0.007 1.73 (1.16, 2.57) 0.165 0.72 (0.45, 1.15) 0.794 0.93 (0.54, 1.61)
Gender (M vs. F) 0.499 1.14 (0.77, 1.71) 0.208 1.31 (0.86, 1.99) 0.350 1.28 (0.76, 2.15)
Smoke exposure*:
- ETS-1 vs. ETS-0 0.38 0.82 (0.53, 1.27) 0.175 0.70 (0.42, 1.17) 0.863 0.95 (0.54, 1.69)
- ETS-2 vs. ETS-0 0.064 0.54 (0.28, 1.04) 0.202 0.65 (0.33, 1.26) 0.536 0.79 (0.38, 1.66)
Family SES Cluster**:
- Low vs. High 0.198 1.88 (0.72, 4.91) 0.840 1.09 (0.49, 2.40) 0.589 0.72 (0.21, 2.41)
- Middle vs. High 0.767 1.13 (0.50, 2.54) 0.379 0.76 (0.41, 1.41) 0.915 1.05 (0.43, 2.54)
Gestational Age 0.173 0.93 (0.83, 1.03) 0.246 1.09 (0.94, 1.28) 0.582 1.06 (0.86, 1.31)
* ETS-0: mother did not smoke during pregnancy and children not exposed to household ETS;
ETS-1: mother did not smoke during pregnancy, but children were exposed to household ETS;
ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
**"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
Table 6 Multivariate analysis of the association of inhalant serum IgE at age 10 with IL13 polymorphisms and prenatal
factors, overall population, stratified by birth order (n = 588) (PR = Prevalence Ratio)
1
st Born 2
nd Born 3
rd and Higher
Study Variables p PR (95% CI) p PR (95% CI) p PR (95% CI)
n = 246 n = 212 n = 130
rs20541:
-AA/GA vs. GG 0.034 1.48 (1.03, 2.13) 0.120 0.72 (0.48, 1.09) 0.197 1.43 (0.83, 2.45)
Gender (M vs. F) 0.353 1.19 (0.82, 1.72) 0.017 1.58 (1.08, 2.29) 0.496 1.20 (0.71, 2.02)
Smoke Exposure*:
- ETS-1 vs. ETS-0 0.075 0.68 (0.44, 1.04) 0.154 0.73 (0.47, 1.13) 0.600 0.84 (0.45, 1.60)
- ETS-2 vs. ETS-0 0.318 0.79 (0.49, 1.26) 0.278 0.74 (0.43, 1.27) 0.672 1.14 (0.60, 2.19)
Family SES Cluster**
- Low vs. High 0.070 2.27 (0.94, 5.49) 0.860 0.92 (0.35, 2.43) 0.058 0.23 (0.05, 1.05)
- Middle vs. High 0.435 1.37 (0.62, 3.04) 0.506 1.26 (0.64, 2.46) 0.349 0.69 (0.31, 1.51)
Gestational age 0.240 0.94 (0.85, 1.04) 0.649 1.03 (0.90, 1.18) 0.095 1.26 (0.96, 1.65)
* ETS-0: mother did not smoke during pregnancy and children not exposed to household ETS;
ETS-1: mother did not smoke during pregnancy, but children were exposed to household ETS;
ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
**"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
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Page 9 of 13Our findings do not result from a selection bias for
several reasons. First, the study cohort maintained high
follow-up proportions throughout the entire study per-
iod: 83.7% (1,218/1456) at age 4; 94.3% (1,373/1456) at
age 10; and 89.6% (1,304/1456) at age 18 years.
Secondly, children who had IgE measurement results
differed only with regard to environmental tobacco
smoke exposure and family social status cluster from
those who had no IgE measurements (Table 2). With
respect to the genotypes, the presence of a selection bias
could result in a violation of the Hardy-Weinberg law.
The genotypes of the five IL13 SNPs were in Hardy-
Weinberg equilibrium and their allele frequencies were
comparable with those of other Caucasian populations
[37,39,40] (Table 1). Hence, concerning the genetic
polymorphisms, a selection bias is unlikely. In addition,
due to the commencement of recruitment and assess-
ments pre-natally, and the use of both questionnaires
and physical examinations for obtaining information
from the participants and their parents, information
bias, if present, was minimal and non-differential. Non-
differential information bias implies that any bias pre-
sent would be similar in both affected and unaffected
children, leading to a bias of the effect estimates towards
the null.
While associations with different SNPs on the same
gene are not considered an indication of disagreement
[1,41,42], we found that two SNPs were related to atopic
outcomes assessed in this study. Thus, our finding that
different SNPs were associated with elevated total serum
IgE (rs1800925), and with inhalant IgE and SPT
(rs20541) is not surprising. Indeed, it is possible that
total serum IgE is an indicator of general susceptibility
(rs1800925 is at the promoter region of IL13), while the
more specific reactions to inhalant allergens and skin
sensitization are related to the non-synonymous (func-
tional) SNP, rs20541 (exonic SNP).
Birth order [10,14,15] and IL13 polymorphisms
[16-21] have each been previously found to be separately
associated with allergy, asthma and atopic markers in
childhood. However, this is the first study that shows an
interaction between birth order and IL13 polymorph-
isms. If confirmed by other researchers, this effect modi-
fication may in part explain the mechanism of the birth
order effect: genetic polymorphisms in the IL13 gene
may undergo epigenetic changes in utero due to condi-
tions specific to a first pregnancy compared to subse-
quent pregnancies. It is now established that the DNA
provides the blueprint for the manufacture of all the
proteins necessary to create a living organism. Nonethe-
less, epigenetic modifications provide additional instruc-
tions on how, where, and when the genetic information
will be used (gene expression). These epigenetic changes
generally involve DNA modification such as methylation
and acetylation, histone protein modifications, and regu-
lation of gene expression by microRNAs [43]. Such
Table 7 Multivariate repeated measurement analysis of the association of positive skin prick test (SPT) at ages 4, 10
and 18 with IL13 and prenatal factors, stratified by birth order (n = 825; obs = 1,305) (PR = Prevalence Ratio)
1
st Born 2
nd Born 3
rd and Higher
Study Variables p PR (95% CI) p PR (95% CI) p PR (95% CI)
(n = 354; obs = 772)
# (n = 287; obs = 634) (n = 184; obs = 414)
rs20541:
-AA/GA vs. GG 0.007 1.35 (1.09, 1.69) 0.045 0.75 (0.56, 0.99) 0.075 1.35 (0.97, 1.89)
Gender (M vs. F) 0.014 1.32 (1.06, 1.66) 0.001 1.50 (1.18, 1.89) 0.082 1.34 (0.96, 1.85)
Environmental Smoke Exposure*:
- ETS-1 vs. ETS-0 0.577 0.93 (0.73, 1.19) 0.698 1.05 (0.81, 1.36) 0.179 0.76 (0.52, 1.13)
- ETS-2 vs. ETS-0 0.020 0.65 (0.45, 0.93) 0.101 0.75 (0.53, 1.06) 0.309 0.79 (0.50, 1.25)
Family SES Cluster**:
- Low vs. High 0.099 1.51 (0.93, 2.45) 0.331 0.73 (0.39, 1.38) 0.006 0.34 (0.16, 1.37)
- Middle vs. High 0.741 1.07 (0.70, 1.64) 0.355 1.24 (0.78, 1.97) 0.091 0.67 (0.43, 1.06)
Gestational Age 0.377 0.96 (0.89, 1.04) 0.033 1.10 (1.01, 1.21) 0.010 1.24 (1.05, 1.47)
# 354 children provided 772 observations because SPT was assessed at 3 separate time-points - 4, 10 and 18 years.
* ETS-0: mother did not smoke during pregnancy and children not exposed to household ETS;
ETS-1: mother did not smoke during pregnancy, but children were exposed to household ETS;
ETS-2: mother smoked during pregnancy and children were exposed to household ETS.
**"Family social status cluster” is a composite variable derived from a combination of family income, parental occupation (socioeconomic status), and number of
children in child’s bedroom.
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Page 10 of 13regulatory mechanisms specify which regions of the gen-
ome are active in any given cell at any one point in time
[44,45]. Inherited changes in the “epigenome” have been
postulated as a possible pathway explaining the differ-
ences in gene expression seen in individuals with identi-
cal “genomes” [46]. Such in utero epigenetic
modifications may result in a higher susceptibility to
increased total IgE levels and allergic sensitization in
first-born children compared to children of higher-order
births.
We have shown that the effect of IL13 polymorphism
was restricted to firstborn children, with individuals car-
rying the homozygous minor and heterozygous geno-
types having a higher relative risk (prevalence ratio)
among firstborns. In addition, there was a lowered rela-
tive risk of the rs20451 SNP in second born, and a
higher relative risk in children with a birth order of
three or greater, although these were not statistically
significant. The recurrence of an increased relative risk
in children with 3
rd or higher order births was not
expected. However, since this group is comprised of
children with different birth orders (three and higher), it
is possible that a long inter-pregnancy interval may
modify the intrauterine environment. In support of this
hypothesis, Wegienka et al. [47] found that children
born after inter-pregnancy intervals of less than 2 years
were less likely to have a positive SPT result compared
with children of mothers with no prior pregnancies.
Since a successful pregnancy is a fine balance between a
mother’s tolerance for her fetus’ foreign genetic material
and the fetus’ ability to survive the maternal immunolo-
gic defenses, Wegienka et al. suggested that prior preg-
nancies and their spacing might influence the
intrauterine environment. It is possible that closely
spaced pregnancies may provide a higher maternal
tolerance.
Our findings suggest adverse prenatal programming in
firstborn offspring. This impact may be related to
immunological differences between a first-born preg-
nancy and later pregnancies from the same partner, as
has been previously documented for the etiology of pre-
eclampsia [13]. However, in order to distinguish the
concept of hygiene hypothesis from that of prenatal pro-
gramming, the greater prevalence of atopy in firstborns
may warrant further investigation. To clarify this issue,
one needs to investigate whether maternal IgE or cord
serum IgE modifies the interaction between birth order
and allergic sensitization. If these prenatal markers are
shown to be effect modifiers, then the observed effect is
more likely to be associatedw i t hp r e n a t a le x p o s u r e s
than with post-natal infections.
The advantages of a birth cohort with prolonged fol-
low-up, such as the Isle of Wight cohort, has been dis-
cussed in the literature as a necessary means to increase
our understanding of genetic diseases, especially atopic
disorders [48]. Unlike other studies that assessed cord
blood IgE at birth as the outcome [49] or that measured
child IgE after a few months or years of follow up [50],
children in the Isle of Wight birth cohort were recruited
prenatally and followed to age 18 years, including
repeated assessments at ages 4, 10 and 18 years. Since
allergy and atopy are dynamic manifestations that can
vary with age due to recoveries and relapses, the long-
term predictive value of the majority of previous studies
was hampered by the short-term follow up period. The
use of data up to age 18 years in this paper addresses
this gap.
Finally, future functional genetic research, including
gene expression and methylation studies, need to deter-
mine whether birth order is related to altered expression
or methylation of the IL13 gene in relation to atopic
outcomes. If we know that the methylation status is
affected, it may be possible to develop interventions dur-
ing pregnancy that could change global or IL13-specific
methylation. Thus, these findings may inform research
into allergy prevention by identifying which specific con-
ditions may modify the altered expression of the IL13
gene in firstborns when compared to second borns.
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